What’s new in lipid management for people with LDL cholesterol levels ≥2.6 mmol/L or heterozygous familial hypercholesterolemia (FH)?

Our host, Dr. George Thanassoulis, takes a deeper look into this topic with Dr. Priya Manjoo, an Endocrinologist and Certified Specialist in both Hypertension and Obesity Medicine at the Victoria Cardiometabolic Collaborative Clinic, and a Clinical Assistant Professor in the Division of Endocrinology at the University of British Columbia’s Faculty of Medicine.

This episode discusses how the recently updated Canadian Cardiovascular Society Guidelines have changed the clinical practice of lipid management in patients with high LDL cholesterol (≥2.6 mmol/L) or heterozygous FH. Our experts also take a closer look at why this patient subgroup is at p ...